Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism

Isabel Cornejo-Pareja,Mohamed Reda Amiar,Luís Ocaña-Wilhelmi,Rocío Soler-Humanes,Isabel Arranz-Salas,Lourdes Garrido-Sánchez,Carolina Gutiérrez-Repiso,Francisco Jose Tinahones
DOI: https://doi.org/10.1007/s00535-023-02075-7
2024-01-26
Journal of Gastroenterology
Abstract:Alterations in gut microbiota are associated with the pathogenesis of metabolic diseases, including metabolic-associated fatty liver disease (MAFLD). The aim of this study was to evaluate gut microbiota composition and functionality in patients with morbid obesity with different degrees of MAFLD, as assessed by biopsy.
gastroenterology & hepatology
What problem does this paper attempt to address?